These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8636072)
1. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072 [TBL] [Abstract][Full Text] [Related]
2. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha. Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794 [TBL] [Abstract][Full Text] [Related]
3. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation. Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201 [TBL] [Abstract][Full Text] [Related]
4. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation. Kuliopulos A; Mohanlal R; Covic L Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748 [TBL] [Abstract][Full Text] [Related]
5. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation. Huang Z; Liu P; Zhu L; Li N; Hu H Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352 [TBL] [Abstract][Full Text] [Related]
6. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase. Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336 [TBL] [Abstract][Full Text] [Related]
7. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
8. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171. Vargaftig B; Joseph D; Hatmi M Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684 [TBL] [Abstract][Full Text] [Related]
9. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
11. p38 mitogen-activated protein kinase activation is required for thromboxane- induced contraction in perfused and pressurized rat mesenteric resistance arteries. Bolla M; Matrougui K; Loufrani L; Maclouf J; Levy B; Levy-Toledano S; Habib A; Henrion D J Vasc Res; 2002; 39(4):353-60. PubMed ID: 12187125 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 stimulates mitogen-activated protein kinase and arachidonic acid liberation in rabbit platelets. Ohkubo S; Nakahata N; Ohizumi Y Prostaglandins; 1996 Nov; 52(5):403-13. PubMed ID: 8948507 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213 [TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin potentiates agonist-stimulated activation of p38 mitogen-activated protein kinase in human platelets. Ezumi Y; Nishida E; Uchiyama T; Takayama H Biochem Biophys Res Commun; 1999 Jul; 261(1):58-63. PubMed ID: 10405323 [TBL] [Abstract][Full Text] [Related]
15. An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. Noeske-Jungblut C; Krätzschmar J; Haendler B; Alagon A; Possani L; Verhallen P; Donner P; Schleuning WD J Biol Chem; 1994 Feb; 269(7):5050-3. PubMed ID: 8106481 [TBL] [Abstract][Full Text] [Related]
16. Aggregation of human and canine platelets: modulation by purine nucleotides. Soslau G; Arabe L; Parker J; Pelleg A Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650 [TBL] [Abstract][Full Text] [Related]
17. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
18. Anisomycin does not activate p38MAPK in human platelets. Pampolina C; McNicol A Thromb Res; 1999 Oct; 96(1):27-35. PubMed ID: 10554082 [TBL] [Abstract][Full Text] [Related]
19. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle. Shaw LA; Batey AJ; Coker SJ Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543 [TBL] [Abstract][Full Text] [Related]
20. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]